Cellectar Biosciences, Inc. Related Party Transaction, Expenses from Transactions with Related Party
Cellectar Biosciences, Inc. (CLRB) reported Related Party Transaction, Expenses from Transactions with Related Party of $0 for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2012-11-06
- Cellectar Biosciences, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2012-09-30 was $0.00.
- Cellectar Biosciences, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2012-06-30 was $51.29K.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month |
|---|---|---|---|
| 2012-09-30 | $0.00 10-Q · filed 2012-11-06 | $51.29K derived: sum of 2 quarters · filed 2012-11-06 | $144.04K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $51.29K 10-Q · filed 2012-08-09 | $144.04K 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |